臨床婦人科産科72巻9号

2018年09月発行

今月の臨床 症例検討会で突っ込まれないための“実践的”婦人科画像の読み方

総論

PET-CT画像：読影時のピットフォール

著者： 津吉秀昭¹ 吉田好雄¹

所属機関： ¹福井大学医学部産科婦人科

ページ範囲：P.855 - P.862

文献概要

●¹⁸F-FDGの特徴をよく理解し，子宮・卵巣を含めた生理的集積の存在と，月経周期による影響を考慮する必要がある．

●特に卵巣がんや子宮肉腫の良悪性の鑑別における有用性はまだ証明されていないため，臨床所見や腫瘍マーカー，他の画像検査も含めた総合的な解釈が必要である．

●再発病変の検出や，リンパ節・遠隔転移の検出における有効性は示されているものの，実施可能施設の制約や費用対効果なども考慮する必要がある．

参考文献

1）Tsuyoshi H, et al : Diagnostic imaging using positron emission tomography for gynecological malignancy. J Obstet Gynaecol Res 43 : 1687─1699, 2017

2）Lerman H, et al : Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients : assessment by PET/CT. J Nucl Med 45 : 266─271, 2004

3）Ding XP, et al : Diagnosis of recurrent uterine cervical cancer : PET versus PET/CT : a systematic review and meta-analysis. Arch Gynecol Obstet 290 : 741─747, 2014

4）Chu Y, et al : Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer : a systematic review and meta-analysis. Nucl Med Commun 35 : 144─150, 2014

5）Bollineni VR, et al : High diagnostic value of 18F-FDG PET/CT in endometrial cancer : systematic review and meta-analysis of the literature. J Nucl Med 57 : 879─885, 2016

6）Kakhki VR, et al : Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients : systematic review and meta-analysis of the literature. Int J Gynecol Cancer 23 : 1536─1543, 2013

7）Xu B, et al : Diagnostic value of positron emission tomography（PET）and PET/computed tomography in recurrent/metastatic ovarian cancer : a meta-analysis. J Obstet Gynaecol Res 43 : 378─386, 2017

8）Suppiah S, et al : Systematic review on the accuracy of positron emission tomography/computed tomography and positron emission tomography/magnetic resonance imaging in the management of ovarian cancer : is functional information really needed? World J Nucl Med 16 : 176─185, 2017

9）Gu P, et al : CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma : a systematic review and meta-analysis. Eur J Radiol 71 : 164─174, 2009

10）Collarino A, et al : Evaluation of dual-timepoint（18）F-FDG PET/CT imaging for lymph node staging in vulvar cancer. J Nucl Med 58 : 1913─1918, 2017

11）Yoshida Y, et al : Assessment of fluorodeoxyglucose uptake by leiomyomas in relation to histopathologic subtype and the menstrual state. J Comput Assist Tomogr 33 : 877─881, 2009

12）Dubreuil J, et al : Diffusion-weighted MRI and 18F-FDG-PET/CT imaging : competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature. Nucl Med Commun 38 : 84─90, 2017

13）Yoshida Y, et al : Additional value of 16alpha-［18F］fluoro-17beta-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocalfindings on［18F］fluorodeoxyglucose PET. Eur J Nucl Med Mol Imaging 38 : 1824─1831, 2011

14）Yamamoto M, et al : 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma. Oncotarget 8 : 22581─22589, 2017